Peter Lio, MD: Updates in AD and Diet

September 15, 2025

Dr. Lio discusses the nuances of approaching patient questions and misconceptions around dietary modifications and restrictions for atopic dermatitis.

MORE COVERAGE FROM MAUI DERM NPPA FALL 2025:

Jennifer Hsiao, MD: Dual Biologic Management in Hidradenitis Suppurativa

Dr. Hsiao discusses efficacy and safety of dual biologic treatment in patients with severe and recalcitrant HS, as well as commonly used biologic combinations that

Neal Bhatia, MD: Topical Therapies Pipeline

Dr. Bhatia discusses upcoming topical therapies while honoring the utility and usefulness of older topical treatments.

Julie Harper, MD: What’s New in Rosacea

Dr. Harper discusses results from head-to-head studies comparing new and existing oral rosacea treatments and navigating the difficulties of treating neurogenic rosacea.

Clive Maopang Liu, MD: Update on Topical Therapy for Psoriasis

Dr. Liu discusses new and emerging topical therapies for psoriasis and the continued value of topical therapies in psoriasis treatment.

Andrea Tesvich Murina, MD: Advancements in Oral Therapies for Psoriasis

Dr. Murina discusses using oral psoriasis drugs as a stepping stone to introduce patients with psoriasis to systemic therapies.

Mark Lebwohl, MD: Special Factors to Consider in Elderly Patients with Psoriasis

Dr. Lebwohl discusses navigating psoriasis treatment in elderly patients, including reduced renal function, increased predisposition to malignancies, and financial burdens of treatment access.

Steven Daniel Daveluy, MD, FAAD: AI Phenotyping of Hidradenitis Suppurativa

Dr. Daveluy discusses an exciting new project to uncover insights into HS disease patterns through analysis with artificial intelligence.

Nada Elbuluk, MD: Skin of Color Primer—Inflammatory Diseases

Dr. Elbuluk discusses unique considerations pertaining to inflammatory skin diseases in patients with skin of color.

Saakshi Khattri, MD: Psoriatic Arthritis Update

Dr. Khattri discusses emerging psoriatic arthritis treatments on the horizon, including deucravacitinib, zasocitinib, and icotrokinra.

James Song, MD, FAAD: Utility of IL-17 Inhibitors for Psoriatic Disease

Dr. Song discusses the specific utility of interleukin (IL)-17 inhibitors when treating psoriatic disease, including in biologic-experienced patients, psoriasis in special sites, and psoriatic arthritis.

Jeffrey Cohen, MD, MPH: Treatment of Psoriasis in High-impact Sites

Dr. Cohen discusses the best biologics for treating psoriasis of the scalp, intertriginous areas, genitals, nails, and palms and soles of the feet.

Ashish Bhatia, MD: New Technologies in Dermatology

Dr. Bhatia reviews exciting new developments in dermatology technology, including a full-body dermoscopic robot, autologous cell transplants for wound healing, and stem cell banking for

JCAD

Journal of Clinical and Aesthetic Dermatology

©2025 JCAD | The Journal of Clinical and Aesthetic Dermatology. All Rights Reserved.